Jiangxi Sanxin Medtec Co Ltd operates within the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jiangxi Sanxin Medtec Co Ltd with three other
companies in this sector in China:
Guangzhou Improve Medical Instruments Company Limited
sales of 549.65 million Chinese Renmimbi [US$79.02 million]
of which 94%
was Medical Industry),
Beijing Bohui Innovation Biotechnology Co Ltd
(443.75 million Chinese Renmimbi [US$63.79 million]
of which 58%
was Diagnose), and
Andon Health Company Limited
(597.92 million Chinese Renmimbi [US$85.96 million]
of which 98%
was medica instruments).
During the year ended December of 2017, sales at
Jiangxi Sanxin Medtec Co Ltd were 403.87 million Chinese Renmimbi (US$58.06 million).
increase of 27.1%
versus 2016, when the company's sales were 317.77 million Chinese Renmimbi.
Sales of Colocation saw an increase
that was more than double the company's growth rate: sales were up
622.9% in 2017, from
14,965.25 Chinese Renmimbi to 108,188.61 Chinese Renmimbi.